News

StockStory.org on MSN4d
The 5 Most Interesting Analyst Questions From PacBio’s Q1 Earnings Call
PacBio’s first quarter of 2025 was shaped by ongoing funding constraints in the academic and research sector, as well as ...
Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue
Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic ...
sharewise3d
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
Pacific Biosciences of California (PACB) closed the most recent trading day at $1.24, moving -3.88% from the previous trading ...
Volta Labs Expands Presence In The Nordic Region With Callisto Placement At Norway's Norwegian Sequencing Centre, University Of Oslo
The NSC, led by Professor Kjetill S. Jakobsen and supported by Lab Manager Dr. Ave Tooming-Klunderud , is a leading center of ...
Technology Networks3d
Computational Tool To Map Paralogous Genes and Copy Number Variation
Paraphase – a computational tool that accurately resolves and analyzes paralogous genes – unlocks the difficult-to-analyze ...
Morningstar2d
Pacific Biosciences of California Inc PACB
Review Pacific Biosciences of California Inc (PACB:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
Morningstar2d
PACB - Pacific Biosciences of California Inc Key Metrics | Morningstar
Review the current Pacific Biosciences of California Inc (PACB:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if PACB is the best investment for you.